Great Lakes Advisors LLC trimmed its holdings in Globe Life Inc. (NYSE:GL - Free Report) by 12.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 197,218 shares of the company's stock after selling 28,921 shares during the period. Great Lakes Advisors LLC owned about 0.24% of Globe Life worth $25,977,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also made changes to their positions in GL. Bank of America Corp DE lifted its position in shares of Globe Life by 10.6% in the fourth quarter. Bank of America Corp DE now owns 387,107 shares of the company's stock valued at $43,170,000 after acquiring an additional 36,986 shares in the last quarter. Baird Financial Group Inc. lifted its position in shares of Globe Life by 27.8% in the fourth quarter. Baird Financial Group Inc. now owns 4,220 shares of the company's stock valued at $471,000 after acquiring an additional 919 shares in the last quarter. Deutsche Bank AG lifted its position in shares of Globe Life by 62.1% in the fourth quarter. Deutsche Bank AG now owns 420,970 shares of the company's stock worth $46,947,000 after buying an additional 161,302 shares in the last quarter. Ethic Inc. lifted its position in shares of Globe Life by 103.6% in the fourth quarter. Ethic Inc. now owns 20,578 shares of the company's stock worth $2,295,000 after buying an additional 10,471 shares in the last quarter. Finally, Graham Capital Management L.P. lifted its position in shares of Globe Life by 46.2% in the fourth quarter. Graham Capital Management L.P. now owns 10,238 shares of the company's stock worth $1,142,000 after buying an additional 3,233 shares in the last quarter. 81.61% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of equities research analysts recently commented on the company. Morgan Stanley boosted their target price on Globe Life from $166.00 to $171.00 and gave the stock an "overweight" rating in a research report on Monday, August 18th. Truist Financial assumed coverage on Globe Life in a research report on Tuesday, July 15th. They issued a "buy" rating and a $150.00 target price on the stock. BMO Capital Markets reiterated a "market perform" rating and issued a $149.00 target price (up from $114.00) on shares of Globe Life in a research report on Wednesday, July 30th. Wall Street Zen upgraded Globe Life from a "hold" rating to a "buy" rating in a research report on Friday, May 16th. Finally, Keefe, Bruyette & Woods boosted their target price on Globe Life from $145.00 to $155.00 and gave the stock an "outperform" rating in a research report on Monday, July 28th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Globe Life presently has a consensus rating of "Moderate Buy" and an average target price of $152.45.
View Our Latest Analysis on Globe Life
Insiders Place Their Bets
In other news, EVP Michael Clay Majors sold 10,000 shares of the company's stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $137.41, for a total transaction of $1,374,100.00. Following the transaction, the executive vice president owned 47,066 shares of the company's stock, valued at approximately $6,467,339.06. This represents a 17.52% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Frank M. Svoboda sold 12,500 shares of the company's stock in a transaction that occurred on Thursday, July 31st. The shares were sold at an average price of $141.38, for a total value of $1,767,250.00. Following the transaction, the chief executive officer directly owned 32,747 shares in the company, valued at approximately $4,629,770.86. This represents a 27.63% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 84,722 shares of company stock worth $11,733,793. Corporate insiders own 1.97% of the company's stock.
Globe Life Trading Down 1.2%
Shares of NYSE GL opened at $139.73 on Monday. The business's 50 day moving average is $132.57 and its two-hundred day moving average is $126.13. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.06 and a quick ratio of 0.06. Globe Life Inc. has a 1-year low of $99.04 and a 1-year high of $144.00. The stock has a market capitalization of $11.32 billion, a P/E ratio of 11.17 and a beta of 0.56.
Globe Life (NYSE:GL - Get Free Report) last released its earnings results on Wednesday, July 23rd. The company reported $3.27 EPS for the quarter, beating analysts' consensus estimates of $3.25 by $0.02. The firm had revenue of $1.48 billion for the quarter, compared to analysts' expectations of $1.50 billion. Globe Life had a return on equity of 21.24% and a net margin of 18.11%.The company's quarterly revenue was up 2.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.97 earnings per share. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS. As a group, research analysts expect that Globe Life Inc. will post 13.87 EPS for the current year.
Globe Life Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, October 3rd will be paid a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, October 3rd. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.8%. Globe Life's dividend payout ratio is currently 8.63%.
Globe Life Company Profile
(
Free Report)
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report